Edition:
United Kingdom

Auris Medical Holding AG (EARS.OQ)

EARS.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
15 Oct 2018
Change (% chg)

$0.40 (+40.82%)
Prev Close
$0.98
Open
$1.39
Day's High
$1.96
Day's Low
$1.26
Volume
9,864,104
Avg. Vol
502,696
52-wk High
$9.50
52-wk Low
$0.23

Chart for

About

Auris Medical Holding AG is a Switzerland-based biotechnology company engaged in developing pharmaceutical products for the treatment of inner ear disorders and mental health supportive care. The Company focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsycho... (more)

Overall

Beta: --
Market Cap(Mil.): $32.28
Shares Outstanding(Mil.): 34.33
Dividend: --
Yield (%): --

Financials

  EARS.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -0.74 -- --
ROI: -112.79 1.70 14.60
ROE: -167.38 3.17 16.33

BRIEF-Auris Medical Receives Positive Scientific Advice From EMA On Development Plan And Regulatory Pathway For AM-111

* AURIS MEDICAL RECEIVES POSITIVE SCIENTIFIC ADVICE FROM EMA ON DEVELOPMENT PLAN AND REGULATORY PATHWAY FOR AM-111

07 May 2018

Earnings vs. Estimates